January 14, 2020
Rose
The judges seemed skeptical of the Trump administration's arguments that Congress implicitly gave HHS authority to require list price disclosure to ensure the "efficient administration" of Medicaid and Medicare. In other pharmaceutical news: drugmakers are testing new ways to pay for pricey treatments, the high cost of medicine is making patients forgo care, and more.
from Kaiser Health News https://ift.tt/2TmZHmk
January 14, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
After Years Of Political Bickering Over Medicaid Expansion, Choice Will Go Directly To Voters In Four Red States- First Edition: October 23, 2018
- Defining A Person’s Sex At Birth And Making It Unchangeable Would Be ‘An Insult To Science,’ Biologists Say
- ‘We Will Not Be Erased’: Fierce Backlash Ignites Over Plan That Would Eradicate Protections For Transgender People
- ‘Top To Bottom’ Review Of Refugee Resettlement Program To Be Conducted By HHS
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment